Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- 43 TV shows to watch in 2014
- 10 classic Sesame Street moments we wouldn't show today's kids
- These 5 things will definitely happen after Obama moves on immigration
- What could happen if the Supreme Court rules against ObamaCare
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- What would a U.S.-Russia war look like?
- 7 grammar rules you really should pay attention to
- The psychology of bribery and corruption
- Why are newspaper comics so terrible?
- 10 things you need to know today: November 20, 2014
Subscribe to the Week